In-vitro Skin Models: Development of Topical and Transdermal Formulations

Published on: 

Sponsored Content

In this seminar, we will talk about two different models that can be used for various in-vitro tests. On demand presentation Register free

Register Free: http://www.pharmtech.com/pt_w/skinmodels

Event Overview:

Transdermal/topical formulations are used in both the pharmaceutical and personal care industries, as they offer some clear benefits to targeted delivery. Human/animal skin models are commonly used for in-vitro testing of these formulations, but these models have multiple challenges, especially in the ever-changing regulatory landscape. As a result, researchers are seeking other options. In this seminar, we will talk about two different models that can be used for various in-vitro tests:

  • A synthetic membrane model (Strat-M® membrane) for in-vitro diffusion testing

  • An organotypic skin model for toxicity and irritation potential studies

Key Learning Objectives

  • Need for in-vitro models in transdermal/topical formulation research

  • Use of a synthetic membrane model (Strat-M® membrane) for in-vitro permeation testing

  • Use of organotypic skin model for toxicity and irritation potential studies

Speaker: Vivek Joshi, PhD, Applications and Market Adoption Manager, Merck KGaA, Darmstadt, Germany

Time and Date: On demand presentation

Sponsor: MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany

Register Free: http://www.pharmtech.com/pt_w/skinmodels